Report data from the single-ascending dose portion of the APOLLO study
Delivered after the deadline (40 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 17 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- 9 Feb 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Silence intends to report data from the single-ascending dose portion of the study in the second half of this year.”
What we found
Evidence strength A What the grades mean
Silence reported positive topline single-ascending dose APOLLO data on 9 February 2022, after the second-half 2021 deadline.
-
A Silence Therapeutics plc 6-K filed 2022-02-09
“Silence Therapeutics Announces Positive Topline Data in SLN360 Phase 1 Single-Ascending Dose Study in Healthy Adults with High Lipoprotein(a)” ✓ confirmed on the page
-
A Silence Therapeutics plc 6-K filed 2022-02-09
“9 February 2022” ✓ confirmed on the page
-
A Silence Therapeutics plc 20-F filed 2022-03-17
“In February 2022, we reported positive topline data in the single-ascending dose cohorts.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- APOLLO study single-ascending dose data
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Silence Therapeutics plc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-SLN-024052 · Corrections policy